Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression
- PMID: 16879867
- DOI: 10.1016/j.leukres.2006.06.012
Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression
Abstract
Multiple myeloma (MM) is a product of interactions between tumor plasma cells and multiple cell types native to the bone marrow (BM). We have used antibody array technology to examine the proteins produced by BM stromal cells in response to stimulation by BM taken from patients diagnosed with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and MM. We observed increased production of the chemokine IL-8 by stromal cells co-cultured with supernatants from bone marrow cells of patients with active myeloma. IL-8 production is correlated with active disease and is dependent upon IL-1beta and NF-kappaB signaling. Consistent with the pro-angiogenic activity of IL-8, increased BM microvessel density (MVD) correlated with stimulation of stromal cell IL-8 production. In addition, the majority of MM cell lines and MM patient plasma cells were found to express IL-8 receptors CXCR1 and CXCR2. We conclude that stromal cell IL-8 production parallels MM disease activity, is IL-1beta induced, and correlates with bone marrow angiogenesis.
Similar articles
-
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.Clin Cancer Res. 2002 Jul;8(7):2210-6. Clin Cancer Res. 2002. PMID: 12114422
-
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.Cancer Res. 2006 Jul 1;66(13):6675-82. doi: 10.1158/0008-5472.CAN-06-0190. Cancer Res. 2006. PMID: 16818641
-
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.Exp Hematol. 2010 Oct;38(10):860-7. doi: 10.1016/j.exphem.2010.06.012. Epub 2010 Jul 7. Exp Hematol. 2010. PMID: 20619313
-
A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.Cancer. 2003 May 15;97(10):2440-52. doi: 10.1002/cncr.11072. Cancer. 2003. PMID: 12733143 Review.
-
Angiogenesis in multiple myeloma.Eur J Cancer. 2006 Jul;42(11):1581-90. doi: 10.1016/j.ejca.2006.02.017. Epub 2006 Jun 23. Eur J Cancer. 2006. PMID: 16797965 Review.
Cited by
-
Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.PLoS One. 2010 May 26;5(5):e10845. doi: 10.1371/journal.pone.0010845. PLoS One. 2010. PMID: 20520765 Free PMC article.
-
The significance of non correlation between interleukin-8 serum levels with bone marrow microvascular density in patients with myeloma multiple.Pathol Oncol Res. 2013 Jul;19(3):539-43. doi: 10.1007/s12253-013-9614-4. Epub 2013 Feb 28. Pathol Oncol Res. 2013. PMID: 23456515
-
Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma.Tumour Biol. 2014 Jun;35(6):5647-51. doi: 10.1007/s13277-014-1747-x. Epub 2014 Feb 23. Tumour Biol. 2014. PMID: 24563338
-
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.Cell Cycle. 2013 Dec 1;12(23):3650-62. doi: 10.4161/cc.26585. Epub 2013 Sep 25. Cell Cycle. 2013. PMID: 24091729 Free PMC article.
-
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells.Mol Cancer. 2010 Jul 6;9:176. doi: 10.1186/1476-4598-9-176. Mol Cancer. 2010. PMID: 20604947 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical